Suchergebnisse - (Standardsuche:issn:"1568-0096" OR issn:"1873-5576")

PubPharm (43)

1

Current Perspectives in Ultra-sensitive Detection of Cancer-specific Biomarkers and Therapeutic Targets

enthalten in: Current cancer drug targets | 2023

von Savvateeva, L. | Zernii, E. | Zamyatnin, A.

2

Role of Natural Nuclear Factor Erythroid-2-related Factor 2 (Nrf2) Activators in Oral and Head and Neck Cancer Treatment

enthalten in: Current cancer drug targets | 2023

von Rekha, K. | Thiruvengadam, M.

3

The Epigenetic Factors that Drive Cancer Drug Resistance

enthalten in: Current cancer drug targets | 2021

von Bacolod, M.

4

Acute Myeloid Leukemia : Changing Treatment Paradigms and Novel Agents in Development

enthalten in: Current cancer drug targets | 2020

von Konig, H. | Zeidner, J.

5

Current Cancer Drug Development Strategies

enthalten in: Current cancer drug targets | 2019

von Shao, J. | Gao, Y.

6

Editorial : Oncolytic Virus and Gene Thearapy Application: Update 2018

enthalten in: Current cancer drug targets | 2018

von Abei, M.

7

Editorial : Cancer Epigenetics

enthalten in: Current cancer drug targets | 2018

von Ahmad, A.

8

Editorial : The Real Impact of Target Therapy in Cancer Patients: Between Hope and Reality

enthalten in: Current cancer drug targets | 2018

von Berretta, M. | Di Francia, R.

9

Editorial : New Therapeutic Approaches for the Treatment of Glioblastoma

enthalten in: Current cancer drug targets | 2017

von Festuccia, C. | Gravina, G.

10

Editorial : Signalling Pathways in Virus-caused Cancers

enthalten in: Current cancer drug targets | 2017

von Chen, J.

1
2
3
4
5
Nächster »
[5]